调强放疗与常规放疗治疗局部晚期鼻咽癌的临床效果比较

2020-08-04 13:55:33鄢少聪应学明熊建萍
中国当代医药 2020年17期

鄢少聪 应学明 熊建萍

[摘要]目的 比較调强放疗(IMRT)与常规放疗(CRT)治疗局部晚期鼻咽癌的临床效果。方法 选取2010年1月~2013年12月南昌大学第一附属医院收治的85例局部晚期鼻咽癌患者作为研究对象,按照治疗方法的不同分为CRT组(39例)和IMRT组(46例)。CRT组采用CRT治疗,IMRT组采用IMRT治疗。比较两组的临床缓解率、5年无局部进展生存率、5年无远处移生存率和总生存率以及早晚期不良反应发生率。结果 IMRT组的临床缓解率为69.5%,高于CRT组的25.6%,差异有统计学意义(P<0.05);IMRT组口干和急性皮肤反应的早期放射损失程度轻于CRT组,差异有统计学意义(P<0.05);IMRT组口干、皮肤纤维化及张口困难的晚期放射损失程度轻于CRT组,差异有统计学意义(P<0.05);IMRT组的5年无局部进展生存率为21.7%,高于CRT组的13.7%,差异有统计学意义(P<0.05)。结论 针对局部晚期鼻咽癌患者采用调强放疗,可显著提高临床缓解率,减轻患者的不良反应,延长患者无局部进展生存时间。

[关键词]鼻咽癌;调强放疗;常规放疗;生存率;不良反应

[中图分类号] R739.62          [文献标识码] A          [文章编号] 1674-4721(2020)6(b)-0080-05

[Abstract] Objective To compare the clinical effect of intensity modulated radiotherapy (IMRT) and conventional radiotherapy (CRT) in the treatment of locally advanced nasopharyngeal carcinoma. Methods Totally 85 patients with locally advanced nasopharyngeal carcinoma admitted into the First Affiliated Hospital of Nanchang University from January 2010 to December 2013 were selected as research subjects. They were divided into the CRT group (n=39) and the IMRT group (n=46) according to different treatment methods. The CRT group was treated with CRT, and the IMRT group was treated with IMRT. The clinical remission rate, 5-year survival rate without local progression, 5-year survival rate without distant migration, overall survival rate and the incidence of early and late adverse reactions were compared between the two groups. Results The clinical remission rate of the IMRT group was 69.5%, which was higher than that of the CRT group accounting for 25.6%, the difference was statistically significant (P<0.05). The degree of early radiation loss of dry mouth and acute skin reactions in the IMRT group were lighter than those of the CRT group, the differences were statistically significant (P<0.05). The degree of late radiation loss of dry mouth, skin fibrosis, and difficulty in opening mouth in the IMRT group were lighter than those of the CRT group, and the differences were statistically significant (P<0.05). The 5-year survival rate without local progression in the IMRT group was 21.7%, which was higher than that of the CRT group accounting for 13.7%, the difference was statistically significant (P<0.05). Conclusion Applying IMRT to patients with locally advanced nasopharyngeal carcinoma can significantly increase the clinical remission rate, alleviate patients′ adverse reactions and prolong the survival time of patients who had no local progression.

[Key words] Nasopharyngeal carcinoma; Intensity modulated radiotherapy; Conventional radiotherapy; Survival rate; Adverse reactions

鼻咽癌是一种原发于鼻咽黏膜处、鼻咽腔顶部以及鼻咽侧壁处的恶性肿瘤,其在我国华南地区尤为高发。由于本病发病部位解剖结构的特殊性,且容易出现局部浸润及淋巴结转移,甚至远处转移[1],使手术治疗受到限制。放化疗结合是局部晚期鼻咽癌的主要治疗手段[2-3],但放疗对病变周围组织的损伤无法避免,且易引起多种并发症。因此,在保证疗效的前提下,减轻不良反应十分重要。本研究对85例初治局部晚期鼻咽癌患者分别采用调强放疗(IMRT)与常规放疗(CRT),现对其临床疗效及毒副反应进行阐述。……

登录APP查看全文